Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire said litigation partner Brandon Walker is encouraging investors who incurred losses in Capricor Therapeutics (CAPR) to contact the firm to discuss potential legal options. The notice provides no details on the alleged issues, losses, claims, or potential financial exposure for Capricor.